Ocular Malignancies Thesis Topics for MS/DNB Ophthalmology
This page brings together ocular malignancies thesis topics for MS Ophthalmology covering retinoblastoma, ocular surface squamous neoplasia, sebaceous carcinoma, eyelid squamous cell carcinoma, basal cell carcinoma, uveal melanoma, choroidal metastasis, orbital lymphoma, lacrimal gland malignancy and conjunctival melanoma. The topics are intended for MS Ophthalmology residents and are framed around designs that can usually be completed within one thesis period using patients, clinical examination, ophthalmic imaging, pathology records and investigations already available through ophthalmology and oncology services. The strongest ocular oncology research topics for MS Ophthalmology use a disease-appropriate reference standard, separate clinical suspicion from confirmed diagnosis and avoid analysing only the surgically verified cases when estimating diagnostic performance. Once a topic is shortlisted, the MS Ophthalmology ocular malignancies protocol and MS Ophthalmology ocular malignancies synopsis should define the tumour category, confirmation pathway, staging variables, primary outcome and feasible statistical plan.
Last reviewed and updated: September 2026 · 2026–27 admissions
Retinoblastoma
Clinical profile and presenting features of children with newly diagnosed retinoblastoma in a tertiary eye hospital: a cross-sectional observational study
Association of delayed presentation with advanced clinical stage in children with retinoblastoma: a cross-sectional analytical study
Correlation of leukocoria duration with severity of retinoblastoma at initial presentation: a cross-sectional analytical study
Association of unilateral versus bilateral retinoblastoma with age and stage at presentation: a comparative cross-sectional study
Diagnostic accuracy of B-scan ultrasonography for detecting calcification in retinoblastoma using clinical diagnosis as reference standard: a diagnostic accuracy study
Correlation of ultrasonographic tumour dimensions with clinical retinoblastoma stage at presentation: a cross-sectional analytical study
Association of presenting signs such as leukocoria and strabismus with advanced retinoblastoma stage: a cross-sectional analytical study
Histopathological profile of enucleated eyes with retinoblastoma and its association with clinical stage: a retrospective observational study
Association of optic nerve invasion on histopathology with clinical features in enucleated retinoblastoma eyes: a retrospective analytical study
Factors associated with treatment abandonment among children diagnosed with retinoblastoma in a tertiary referral hospital: a retrospective observational study
Ocular Surface Squamous Neoplasia
Clinical profile of patients presenting with ocular surface squamous neoplasia in a tertiary eye hospital: a cross-sectional observational study
Association of lesion size and location with histopathological severity in ocular surface squamous neoplasia: a cross-sectional analytical study
Diagnostic accuracy of slit-lamp clinical examination for ocular surface squamous neoplasia using histopathology as reference standard: a diagnostic accuracy study
Association of ultraviolet light exposure with ocular surface squamous neoplasia among outdoor workers: a case-control study
Association of smoking and tobacco use with ocular surface squamous neoplasia in adults: a case-control study
Clinical differences between conjunctival intraepithelial neoplasia and invasive squamous cell carcinoma of the ocular surface: a comparative cross-sectional study
Association of corneal involvement with histopathological severity in ocular surface squamous neoplasia: a cross-sectional analytical study
Agreement between two ophthalmologists for clinical grading of ocular surface squamous neoplasia using slit-lamp photographs: an inter-observer agreement study
Association of delayed presentation with larger lesion size in ocular surface squamous neoplasia: a cross-sectional analytical study
Histopathological pattern and surgical margin status in excised ocular surface squamous neoplasia: a retrospective record-based study
Sebaceous Carcinoma of the Eyelid
Clinical profile and presenting features of patients with sebaceous carcinoma of the eyelid: a cross-sectional observational study
Association of delayed diagnosis with tumour size in sebaceous carcinoma of the eyelid: a cross-sectional analytical study
Clinical features differentiating sebaceous carcinoma from benign eyelid lesions using histopathology as reference standard: a diagnostic accuracy study
Association of upper eyelid involvement with clinical severity of sebaceous carcinoma: a cross-sectional analytical study
Frequency and clinical predictors of regional lymph node involvement in sebaceous carcinoma of the eyelid: a retrospective observational study
Association of tumour size with histopathological differentiation in sebaceous carcinoma of the eyelid: a cross-sectional analytical study
Association of pagetoid spread with clinical characteristics of sebaceous carcinoma of the eyelid: a retrospective analytical study
Correlation of duration of symptoms with tumour dimensions in patients with sebaceous carcinoma of the eyelid: a cross-sectional study
Clinical profile of sebaceous carcinoma initially misdiagnosed as chalazion or blepharitis: a retrospective observational study
Association of surgical margin involvement with tumour size and location in excised sebaceous carcinoma of the eyelid: a retrospective analytical study
Squamous Cell Carcinoma of the Eyelid
Clinical profile of patients presenting with squamous cell carcinoma of the eyelid: a cross-sectional observational study
Association of tumour size with histopathological grade in squamous cell carcinoma of the eyelid: a cross-sectional analytical study
Association of ultraviolet exposure with eyelid squamous cell carcinoma among outdoor workers: a case-control study
Clinical accuracy of suspected eyelid squamous cell carcinoma using histopathology as reference standard: a diagnostic accuracy study
Association of delayed presentation with advanced local involvement in eyelid squamous cell carcinoma: a cross-sectional analytical study
Clinical characteristics of upper versus lower eyelid squamous cell carcinoma: a comparative cross-sectional study
Association of ulceration with histopathological differentiation in eyelid squamous cell carcinoma: a cross-sectional analytical study
Frequency and predictors of regional lymph node involvement in eyelid squamous cell carcinoma: a retrospective observational study
Association of tumour location with surgical margin involvement in excised eyelid squamous cell carcinoma: a retrospective analytical study
Histopathological patterns of eyelid squamous cell carcinoma diagnosed in a tertiary eye hospital: a retrospective record-based study
Basal Cell Carcinoma of the Eyelid
Clinical profile and anatomical distribution of basal cell carcinoma of the eyelid: a cross-sectional observational study
Association of ultraviolet exposure with basal cell carcinoma of the eyelid in adults: a case-control study
Diagnostic accuracy of clinical examination for basal cell carcinoma of the eyelid using histopathology as reference standard: a diagnostic accuracy study
Association of tumour size with duration of symptoms in basal cell carcinoma of the eyelid: a cross-sectional analytical study
Comparison of clinical characteristics of nodular and ulcerative basal cell carcinoma of the eyelid: a comparative cross-sectional study
Association of medial canthal location with larger tumour size in basal cell carcinoma of the eyelid: a cross-sectional analytical study
Association of pigmentation with clinical diagnosis of basal cell carcinoma in Indian patients: a cross-sectional analytical study
Correlation of clinical tumour dimensions with histopathological dimensions in basal cell carcinoma of the eyelid: a correlation study
Association of tumour size and site with surgical margin involvement in eyelid basal cell carcinoma: a retrospective analytical study
Histopathological subtypes and clinical features of basal cell carcinoma of the eyelid: a retrospective observational study
Uveal Melanoma
Clinical and ultrasonographic profile of patients with newly diagnosed uveal melanoma in a tertiary eye hospital: a cross-sectional study
Correlation of tumour thickness on B-scan ultrasonography with presenting visual acuity in choroidal melanoma: a cross-sectional analytical study
Association of tumour location with visual impairment at presentation in patients with choroidal melanoma: a cross-sectional analytical study
Correlation of basal tumour diameter with ultrasonographic tumour thickness in choroidal melanoma: a cross-sectional study
Association of retinal detachment with tumour dimensions in patients with choroidal melanoma: a cross-sectional analytical study
Diagnostic accuracy of B-scan ultrasonography for suspected choroidal melanoma using final clinical diagnosis as reference standard: a diagnostic accuracy study
Association of delayed presentation with larger tumour dimensions in patients with uveal melanoma: a cross-sectional analytical study
Comparison of presenting characteristics of choroidal and ciliary body melanoma: a comparative cross-sectional study
Association of tumour pigmentation with ultrasonographic and clinical characteristics of choroidal melanoma: a cross-sectional analytical study
Clinical and histopathological profile of enucleated eyes with uveal melanoma in an Indian tertiary centre: a retrospective study
Choroidal Metastasis
Clinical profile and presenting ocular symptoms of patients diagnosed with choroidal metastasis: a retrospective observational study
Association of choroidal metastasis location with presenting visual acuity: a cross-sectional analytical study
Correlation of tumour thickness on B-scan ultrasonography with visual impairment in choroidal metastasis: a cross-sectional study
Association of subretinal fluid with visual acuity in eyes with choroidal metastasis: a cross-sectional analytical study
Comparison of ocular features of solitary and multiple choroidal metastases: a comparative cross-sectional study
Frequency of previously undiagnosed systemic malignancy among patients presenting initially with choroidal metastasis: a retrospective study
Comparison of choroidal metastases arising from breast and lung malignancies according to clinical ocular features: a comparative study
Diagnostic accuracy of clinical examination and ultrasonography for choroidal metastasis using final oncological diagnosis as reference standard: a diagnostic accuracy study
Association of bilateral ocular involvement with primary systemic malignancy type in patients with choroidal metastasis: a retrospective analytical study
Clinical spectrum of choroidal metastasis presenting to an ophthalmic oncology service in a tertiary hospital: a retrospective observational study
Orbital Lymphoma
Clinical profile and presenting ocular manifestations of patients with orbital lymphoma: a retrospective observational study
Association of duration of symptoms with extent of orbital involvement in patients with orbital lymphoma: a cross-sectional analytical study
Comparison of clinical presentation of lacrimal gland and non-lacrimal orbital lymphoma: a comparative cross-sectional study
Association of proptosis severity with anatomical location of orbital lymphoma: a cross-sectional analytical study
Frequency of bilateral orbital involvement among patients with lymphoma presenting to an ophthalmology service: a retrospective study
Clinical features predicting lymphoma among patients undergoing biopsy for an orbital mass: a diagnostic accuracy study
Association of age with anatomical distribution of orbital lymphoma: a cross-sectional analytical study
Comparison of ocular motility limitation in superior and inferior orbital lymphoma: a comparative cross-sectional study
Correlation of clinical tumour extent with histopathological subtype in orbital lymphoma: a retrospective analytical study
Histopathological spectrum and ophthalmic presentation of orbital lymphoma in an Indian tertiary hospital: a retrospective study
Lacrimal Gland Malignancy
Clinical profile of patients presenting with malignant epithelial tumours of the lacrimal gland: a retrospective observational study
Association of pain with malignant histopathology in patients presenting with lacrimal gland masses: a diagnostic accuracy study
Clinical features differentiating malignant from benign lacrimal gland epithelial tumours using histopathology as reference standard: a diagnostic accuracy study
Association of symptom duration with tumour size in malignant lacrimal gland tumours: a cross-sectional analytical study
Clinical profile of adenoid cystic carcinoma of the lacrimal gland in adults: a retrospective observational study
Association of pain and sensory symptoms with adenoid cystic carcinoma of the lacrimal gland: a cross-sectional analytical study
Comparison of clinical characteristics of adenoid cystic carcinoma and pleomorphic adenoma of the lacrimal gland: a comparative study
Association of proptosis severity with tumour size in malignant lacrimal gland tumours: a cross-sectional analytical study
Correlation of duration of symptoms with visual impairment in patients with malignant lacrimal gland tumours: a cross-sectional study
Histopathological spectrum of malignant lacrimal gland tumours diagnosed in a tertiary referral hospital: a retrospective study
Conjunctival Melanoma
Clinical profile and anatomical distribution of conjunctival melanoma in patients presenting to a tertiary eye hospital: a retrospective study
Association of tumour location with clinical extent of conjunctival melanoma at presentation: a cross-sectional analytical study
Association of pigmentation pattern with histopathological diagnosis in suspected conjunctival melanoma: a cross-sectional analytical study
Diagnostic accuracy of slit-lamp examination for suspected conjunctival melanoma using histopathology as reference standard: a diagnostic accuracy study
Association of lesion size with histopathological invasion in conjunctival melanoma: a cross-sectional analytical study
Comparison of clinical features of conjunctival melanoma and conjunctival pigmented nevus: a comparative cross-sectional study
Association of delayed presentation with larger lesion size in patients with conjunctival melanoma: a cross-sectional analytical study
Agreement between two ophthalmologists for photographic assessment of conjunctival melanoma extent: an inter-observer agreement study
Association of tumour location with surgical margin involvement in excised conjunctival melanoma: a retrospective analytical study
Clinical and histopathological profile of conjunctival melanoma diagnosed in an Indian tertiary eye hospital: a retrospective observational study
Not the ophthalmology subspeciality you need? Ocular malignancies is one section of our full ophthalmology collection — the hub page lists every subspeciality, each with its own free topic list. Updated September 2026.
📌 Updated for 2026–2027 MS Ophthalmology Ocular Malignancies admissions
The list was reviewed for feasibility in departments where ocular oncology research depends on referral volume, clinical photography, ultrasonography, histopathology and multidisciplinary records.
Many topics can be completed from slit-lamp findings, fundus examination, B-scan ultrasonography, pathology reports and routine oncology records; advanced molecular testing is not essential for most resident projects.
Retrospective record-based, cross-sectional, comparative, case-control, agreement and carefully designed diagnostic-accuracy studies are usually more feasible than prospective survival or recurrence studies requiring prolonged follow-up.
Publication potential is strongest when tumour definitions, staging systems and confirmation methods are prespecified and the analysis avoids verification bias from including only biopsied, excised or enucleated cases.
Generate a protocol from any topic above
Select Generate Protocol → beside any title in the list above and receive a submission-ready document built around that topic, containing all eighteen components:
Introduction / Synopsis
Research Question
Aim of the Study
Primary Objective
Secondary Objectives
Materials and Methods
Inclusion Criteria
Exclusion Criteria
Sample Size Calculation
Methodology
Statistical Analysis
Ethical Considerations
Review of Literature
References
Gantt Chart / Study Timeline
Patient Information Sheet
Consent Form
Data Collection Form
Already have your thesis title?
Generate the full ocular malignancies protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.
Alongside ocular malignancies protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.
The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the ocular malignancies research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.
Board and residency programmes — country by country
Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the ocular malignancies research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.
United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare an ocular malignancies research protocol for their programme and submit it for institutional review board approval before any data are collected.
Qatar — DHP (formerly QCHP) and Hamad Medical Corporation. A ocular malignancies IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.
Bahrain — NHRA. Trainees turning ocular malignancies research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.
Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the ocular malignancies research proposal is the document assessed at the start of it.
Kuwait — KIMS. A ocular malignancies study protocol goes to the institutional committee for approval before the project begins.
Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the ocular malignancies proposal follows the same structure throughout.
Postgraduate degrees — Malaysia, the Gulf and beyond
Malaysia — MMed, the National Medical Research Register and MREC. A ocular malignancies dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.
PhD and Master's candidates elsewhere. University programmes generally require a full ocular malignancies research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.
PhD and MMed proposals are written individually by a medical doctor and revised until the supervisor accepts them. They are not produced by the automated protocol generator.
🔥 Trending research areas in Ocular Malignancies for 2026–27
Resident-level ocular oncology research is increasingly centred on earlier recognition, clinicopathological correlation and factors associated with delayed diagnosis or advanced presentation.
Delayed presentation and advanced disease: retinoblastoma, eyelid carcinoma and conjunctival malignancy offer clinically important questions around symptom duration, referral delay and stage at diagnosis.
Clinicopathological correlation: tumour size, location, pigmentation, ulceration, pagetoid spread and surgical margin status can be studied against histopathology when tissue diagnosis is part of routine care.
Ophthalmic imaging in intraocular tumours: B-scan ultrasonography remains useful for tumour dimensions, calcification, retinal detachment and other features when the clinical diagnosis is defined independently.
Ocular presentation of systemic malignancy: choroidal metastasis and orbital lymphoma allow research on ocular signs that may precede or accompany systemic oncological diagnosis.
Protocol and synopsis guidance
What an Ocular Malignancies protocol must contain
Define the tumour and confirmation pathway. State whether the diagnosis is clinical, imaging-supported, histopathologically confirmed or established by multidisciplinary oncological assessment. The reference standard should be appropriate to the tumour; histopathology is not automatically available or appropriate for every intraocular malignancy.
Use a recognised staging or extent definition. Retinoblastoma stage, eyelid tumour extent, conjunctival involvement, orbital spread, optic nerve invasion, lymph node involvement and metastatic status should be defined with the same criteria for every participant. Avoid creating post hoc severity categories after reviewing the outcomes.
Separate index test from reference standard. A slit-lamp diagnosis, B-scan feature or clinical sign being evaluated must be interpreted without knowledge of the definitive diagnosis whenever feasible. If only test-positive or surgically treated cases receive histopathology, the resulting diagnostic accuracy can be biased.
Fix the unit of analysis and timing. State whether the unit is the patient, eye, eyelid lesion, conjunctival lesion or tumour. For bilateral disease or multiple lesions, specify how clustering will be handled. Clinical dimensions and imaging should be recorded at a defined pre-treatment time point when correlation with pathology or stage is planned.
Ocular Malignancies synopsis versus Ocular Malignancies protocol
The synopsis gives the concise scientific plan. It should identify the tumour group, study population, principal clinical or imaging variable, confirmation method, primary outcome, study design and proposed analysis.
The protocol gives the operational detail. It should specify diagnostic criteria, staging system, imaging technique, pathological variables, clinical photography method, masking of assessors where relevant, treatment status, rules for multiple lesions or bilateral disease, and how incomplete oncology records will be handled.
Confirmation differs across ocular tumours. An excised eyelid carcinoma can be correlated directly with histopathology, whereas retinoblastoma or choroidal melanoma may be managed without pre-treatment biopsy. The protocol should therefore state the disease-specific final diagnosis pathway rather than applying one reference standard to every malignancy.
Sample size and statistical analysis
Base sample size on the main objective. Descriptive studies use an expected proportion with chosen precision, case-control studies use an anticipated exposure difference or odds ratio, correlation studies use an expected correlation coefficient, and diagnostic-accuracy studies require an anticipated sensitivity or specificity together with the expected prevalence of disease.
Match the unit of analysis to the question. Bilateral retinoblastoma produces two eyes within one child, and one patient may have more than one conjunctival or eyelid lesion. Those observations are not automatically independent. The protocol should use a prespecified index lesion, a patient-level outcome or a statistical method that accounts for clustering.
Distinguish association from diagnostic performance. Tumour size and stage associations may use regression models, agreement between observers requires an agreement statistic, and diagnostic studies require sensitivity, specificity and predictive values against a defensible reference standard. Retrospective studies should prespecify how missing pathology, imaging, staging and follow-up data will be handled rather than excluding incomplete records without explanation.
1. How do I choose a feasible Ocular Malignancies thesis topic?
For 2026–2027 admissions, begin with the malignancies actually seen in sufficient numbers at the institution and with the records that can be retrieved reliably. Retinoblastoma, ocular surface squamous neoplasia and common eyelid malignancies are usually more feasible than rare orbital or lacrimal tumours in a low-volume centre. A retrospective clinicopathological or presentation-stage study may be stronger than a prospective project that cannot recruit enough cases within the dissertation period.
2. Which study designs are commonly accepted for Ocular Malignancies thesis work?
Useful designs include retrospective record-based studies, cross-sectional observational and analytical studies, comparative studies, case-control studies, clinicopathological correlation studies, observer-agreement studies and diagnostic-accuracy studies. Prospective outcome studies are possible when case volume and follow-up are predictable, but long survival or recurrence endpoints may exceed the thesis period.
3. What should I settle with my guide before finalising an Ocular Malignancies topic?
Settle the exact tumour type, case definition, staging or extent classification, confirmation method, study unit, primary outcome, treatment status and availability of pathology and imaging records. If diagnostic accuracy is planned, agree in advance on the index test, reference standard, assessor masking and what happens to participants who do not undergo biopsy or surgery.
4. What should I do when an ocular malignancy is too rare for a prospective thesis?
Use the existing case archive rather than forcing a small prospective cohort. A retrospective study can examine presentation, imaging, histopathology, staging, referral delay, surgical margins or treatment abandonment if the records are sufficiently complete. Broader but clinically coherent groups, such as malignant eyelid tumours, may also be feasible when a single rare histological subtype would produce too few cases.
5. What is the difference between an Ocular Malignancies synopsis and an Ocular Malignancies protocol?
The synopsis summarises the research question, rationale, objectives, design, tumour group, confirmation method and planned analysis. The protocol provides the full operating definitions, staging criteria, pathology variables, imaging methods, study-unit rules, assessor masking, record-retrieval plan, missing-data strategy and statistical methods needed to reproduce the study.
6. What ethical issues are important in Ocular Malignancies research?
Prospective studies require informed consent, while retinoblastoma and other paediatric studies require guardian consent with age-appropriate child assent from about seven years where feasible. Record-based studies may seek a waiver of consent when permitted by the ethics committee. Research should not delay biopsy, enucleation, systemic staging or oncological treatment, and should not add CT radiation, MRI contrast, venepuncture or other procedures solely for research unless specifically justified and approved. Any research-only blood sampling should have a stated volume limit appropriate to age and body size. Separate consent should be obtained for identifiable external-eye photographs or video. Imaging and pathology data should be anonymised; DICOM headers and reconstructed facial surfaces can contain identifiers. The protocol should name the pathway for urgent incidental findings such as suspected extraocular extension, regional nodal disease, bilateral retinoblastoma or a previously unrecognised systemic malignancy requiring immediate oncological referral.
7. Can histopathology be used as the reference standard for every ocular malignancy study?
No. Histopathology is an appropriate reference standard when tissue is routinely obtained, such as after excision of many eyelid, conjunctival or lacrimal lesions. It is not automatically appropriate for retinoblastoma, choroidal melanoma, choroidal metastasis or other tumours where biopsy may be avoided and the final diagnosis may rely on clinical examination, imaging, treatment response or multidisciplinary oncological assessment. Restricting analysis to lesions that underwent biopsy, excision or enucleation can also create verification bias, because clinically obvious or advanced cases are more likely to receive tissue confirmation. The protocol should define a tumour-specific final diagnosis pathway and account for unverified cases rather than silently excluding them.
8. Can an Ocular Malignancies thesis also support PhD or Gulf board research pathways?
Yes, but the expected depth and documentation differ. A PhD proposal usually requires a broader research gap, stronger methodological justification and a programme of work beyond the scope of an MS dissertation, whereas an MS synopsis is usually centred on one feasible thesis question. SCFHS and Saudi Board trainees may also need a mandatory board research project, while the Arab Board of Health Specializations and DHP, DHA, DOH and MOHAP-linked training programmes may use their own proposal, ethics and submission pathways. The scientific topic may overlap, but the document should be prepared for the specific programme.
9. When should I register my Ocular Malignancies thesis topic?
Register after confirming adequate case volume or a sufficiently complete retrospective archive, access to pathology and imaging records, guide agreement on the tumour definition and confirmation pathway, and a primary outcome that can be completed within the dissertation period. Prospective recruitment or collection of research-specific measurements should begin only after institutional and ethics requirements are complete.
Found a topic that fits your department?
Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.
